Name | LY3143921 |
---|
Description | LY3143921 (LY-3143921) is an orally available, potent, selective inhibitor of Cdc7 kinase inhibitor, inhibits CDC7/DBF4 I and pMCM2 (S53) with IC50 values of 3.3 nM and 290 nM, respectively. Solid Tumors Phase 1 Clinical |
---|---|
References | References View Related Products by Target Cyclin-dependent Kinase (CDK) Solid Tumors |
Molecular Formula | C16H14FN5O2 |
---|---|
Molecular Weight | 327.319 |